PDS Biotechnology Corporation
PDSB
$0.79
$0.022.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.60% | -17.95% | -3.50% | -3.75% | -17.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.03% | -12.22% | -9.82% | -29.27% | -3.24% |
| Operating Income | 20.03% | 12.22% | 9.82% | 29.27% | 3.24% |
| Income Before Tax | 16.01% | -2.58% | 8.91% | 27.03% | 1.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.01% | -13.28% | 19.94% | 27.03% | 1.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.01% | -13.28% | 19.94% | 27.03% | 1.13% |
| EBIT | 20.03% | 12.22% | 9.82% | 29.27% | 3.24% |
| EBITDA | 20.06% | 12.24% | 9.84% | 29.32% | 3.25% |
| EPS Basic | 34.04% | 9.47% | 31.22% | 38.38% | 16.98% |
| Normalized Basic EPS | 34.05% | 18.00% | 21.70% | 38.35% | 17.00% |
| EPS Diluted | 34.04% | 9.47% | 31.22% | 38.38% | 16.98% |
| Normalized Diluted EPS | 34.05% | 18.00% | 21.70% | 38.35% | 17.00% |
| Average Basic Shares Outstanding | 27.34% | 25.10% | 16.39% | 18.40% | 19.07% |
| Average Diluted Shares Outstanding | 27.34% | 25.10% | 16.39% | 18.40% | 19.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |